A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
9 April, 2026
Vale Professor Jim Denham OAM, TROG founder and world-class researcher
9 April 2026 TROG Cancer Research honours the life
31 March, 2026
TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes
LATEST NEWS: 31 March 2026 TROG’s inaugural Secondary Data